Shares of Artemis Therapeutics Inc. (OTCMKTS:ATMS) dropped 5.7% during trading on Wednesday . The stock traded as low as $2.50 and last traded at $2.50. Approximately 800 shares were traded during mid-day trading, a decline of 88% from the average daily volume of 6,422 shares. The stock had previously closed at $2.65.
The firm’s 50 day moving average price is $1.24.
Artemis Therapeutics Company Profile (OTCMKTS:ATMS)
Artemis Therapeutics Inc does not have significant operations. Previously, it was engaged in the development of agents for the prevention and treatment of severe and life-threatening infectious diseases. The company is based in New York, New York. Artemis Therapeutics Inc is a subsidiary of Tonak Ltd.
Read More: How a Put Option Works
Receive News & Ratings for Artemis Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Artemis Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.